Youngsoo K. Kim
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 275 publications
Quantitative Assessment of Particulate Matter Biodistribution Using 14C-Nanotracing and Accelerator Mass Spectrometry.
Journal: Environmental science & technology
Published: January 13, 2026
Small Molecule Therapeutics Targeting Amyloid-β in Alzheimer's Disease: Mechanisms, Clinical Progress, and Future Strategies.
Journal: Experimental neurobiology
Published: October 24, 2025
Fucoxanthin Extracted from the Microalgae Phaeodactylum tricornutum Ameliorates Alzheimer's Pathologies with the Reduction of Aβ-Induced NLRP3 Inflammasome Activation in APP/PS1 Mice.
Journal: Molecular neurobiology
Published: September 09, 2025
Temporal proteomic characterization of SARS-CoV-2 infected mouse lungs.
Journal: Molecular & cellular proteomics : MCP
Published: August 24, 2025
Clearance of amyloid plaque via focused ultrasonication in a mouse model of Alzheimer's disease.
Journal: Theranostics
Published: July 21, 2025
Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features.
Journal: Clinical and molecular hepatology
Published: July 17, 2025
Postpartum Brain Reveals Repopulating Process and Long-Lasting Proteomic Changes of Microglia.
Journal: Glia
Published: May 16, 2025
Integrative multi-omics refines the molecular subtypes of thyroid cancers and enhances cancer-progression prediction: a retrospective cohort study.
Journal: International journal of surgery (London, England)
Published: May 15, 2025
Tau Repeats Disassemble Amyloid-β Fibrils In Vitro by Interacting with KLVFFA and GGVVIA Domains.
Journal: ACS chemical neuroscience
Published: April 14, 2025
Study on the pharmacokinetics and distribution of exogenous taurine in a brain by 14C-nanotracing technique based on accelerator mass spectrometry.
Journal: Journal of pharmaceutical and biomedical analysis
Published: March 07, 2025
Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls.
Journal: Experimental neurobiology
Published: February 20, 2025
Last Updated: 09/26/2026